<p>54.52% of the vGluT1 + and 63.55% of the vGluT1 − presynaptic boutons localized CB1 silver-intensified gold particles along their membranes. B, Percentages of CB1 immunopositive synaptic terminals in the anterolateral BNST of wild-type (45.40±4.737%), CB1-KO (2.063±1.411%), GABA-CB1-KO (30.93±3.309%) and Glu-CB1-KO (33.83±3.099) mutant mice. Immunolabeling was negligible in CB1-KO tissue. C, Density of CB1 immunoparticles in vGluT1 + and vGluT1 − synaptic membranes after subtraction of background labeling (0.08 particles/µm), and area analyzed in each tissue condition.</p
Several lines of evidence indicate that cannabinoids, among other functions, are involved in motor c...
<p>A representative confocal image of staining for CB2 receptors (green, H60 antibody) in the cortex...
<p>Quantification of the co-localization of CB1 receptor immunoreactivity with GAD67 and glutamate i...
<p>Double labeling by combining a preembedding immunogold (CB1) and an immunoperoxidase (vGluT1) met...
<p>(A) Double immunofluorescent staining of CB1 (magenta) and MAP2 (green) in the upper layer of V1....
<p>(A) shows the pattern of CB1 immunoreactivity within the hippocampus of WT mouse tissue. (A 1) an...
<p>A: 20.5±1.3% of the synaptic terminals/preterminals are CB<sub>1</sub>R immunopositive in <i>CB<s...
<p>A: 24.0±2.9% of synaptic terminals making asymmetric and 28.9±7.5% of terminals with symmetric sy...
<p>Preembedding immunogold method for electron microscopy. A, B: In <i>CB<sub>1</sub>R</i>-WT, CB<su...
<p>(A) Coimmunostaining against CB1 receptor and dendritic marker MAP2 on 28 days in vitro (DIV) cor...
<p>(A) shows the pattern of VGLUT3 immunoreactivity within the hippocampus of WT mouse tissue. (A 1)...
<p>Double preembedding immunogold and immunoperoxidase methods for electron microscopy. (A, B) mGluR...
<p>(A) Expression of EGFP-tagged CB1 (CB1-EGFP) in mouse brain 4 wk after cortical injection of rAAV...
<p>(A) Representative western blots of CB1 and GAPDH in V1. The blots of normal light/dark condition...
<p>Representative low-magnification (4 x) showing CB1-IR throughout the hippocampus of WT (A) and IR...
Several lines of evidence indicate that cannabinoids, among other functions, are involved in motor c...
<p>A representative confocal image of staining for CB2 receptors (green, H60 antibody) in the cortex...
<p>Quantification of the co-localization of CB1 receptor immunoreactivity with GAD67 and glutamate i...
<p>Double labeling by combining a preembedding immunogold (CB1) and an immunoperoxidase (vGluT1) met...
<p>(A) Double immunofluorescent staining of CB1 (magenta) and MAP2 (green) in the upper layer of V1....
<p>(A) shows the pattern of CB1 immunoreactivity within the hippocampus of WT mouse tissue. (A 1) an...
<p>A: 20.5±1.3% of the synaptic terminals/preterminals are CB<sub>1</sub>R immunopositive in <i>CB<s...
<p>A: 24.0±2.9% of synaptic terminals making asymmetric and 28.9±7.5% of terminals with symmetric sy...
<p>Preembedding immunogold method for electron microscopy. A, B: In <i>CB<sub>1</sub>R</i>-WT, CB<su...
<p>(A) Coimmunostaining against CB1 receptor and dendritic marker MAP2 on 28 days in vitro (DIV) cor...
<p>(A) shows the pattern of VGLUT3 immunoreactivity within the hippocampus of WT mouse tissue. (A 1)...
<p>Double preembedding immunogold and immunoperoxidase methods for electron microscopy. (A, B) mGluR...
<p>(A) Expression of EGFP-tagged CB1 (CB1-EGFP) in mouse brain 4 wk after cortical injection of rAAV...
<p>(A) Representative western blots of CB1 and GAPDH in V1. The blots of normal light/dark condition...
<p>Representative low-magnification (4 x) showing CB1-IR throughout the hippocampus of WT (A) and IR...
Several lines of evidence indicate that cannabinoids, among other functions, are involved in motor c...
<p>A representative confocal image of staining for CB2 receptors (green, H60 antibody) in the cortex...
<p>Quantification of the co-localization of CB1 receptor immunoreactivity with GAD67 and glutamate i...